FDA-APPROVED INDICATIONS Type 2 diabetes As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus Limitations of use: has not been studied in patients with a history of pancreatitis TYPE 2 DIABETES RCT SURPASS-2 trial - Tirzepatide vs Semaglutide in Patients with Type 2 Diabetes, NEJM (2021) [PubMed abstract] The SURPASS-2 trial enrolled 1879 adults with type 2 diabetes who were inadequately controlled with metformin at a dose of at least 1500 mg per day Main inclusion criteria Age 18 years T2DM uncontrolled with metformin at 1500 mg/day A1C of 7 - 10.5% BMI 25 and stable for 3 months Main exclusion criteria Type 1 diabetes GFR 50 ng/L
Safety is a top priority when it comes to weight loss medications
Retatrutide maintains a good safety profile in phase 2 trials, like other GLP-1 receptor agonists
Shes authored a variety of books, including When I Go Low (for kids), Pregnancy with Type 1 Diabetes, and Dealing with Diabetes Burnout. Gingers also written for Diabetes Mine, Healthline, T1D Exchange, Diabetes Strong and more
Anyone considering peptide-related products for personal health should speak with a licensed healthcare professional instead of relying on online dosage charts or informal recommendations